Analysis of Th17 and Tc17 Frequencies and Antiviral Defenses in Gut-Associated Lymphoid Tissue of Chronic HIV-1 Positive Patients
Table 2
Frequencies of Tc17 and Tc1 in peripheral blood and gut-associated lymphoid tissue (GALT) samples collected from HIV-1-infected patients () who achieved virological suppression in response to ART therapy.
Frequencies
GALT
Peripheral blood
values
Tc17 cells (median/range)
0.21/0.00–1.50
0.03/0.00–0.1
Tc1 cells (median/range)
10.59/0.32–56.34
0.36/0.0–58.24
CD8+ DP T cells (median/range)
0.095/0.0–1.16
0.005/0.0–0.11
Naïve Tc17 cells (median/range)
0.17/0.0–1.9
0.11/0.0–0.27
Naïve Tc1 cells (median/range)
6.24/0.37–41.74
0.49/0.0–31.61
Naïve CD8+ DP T cells (median/range)
0.0/0.0–0.41
0.01/0.0–0.07
Central memory Tc17 cells (median/range)
0.16/0.0–1.47
0.05/0.00–0.51
Central memory Tc1 cells (median/range)
15.38/0.52–58.75
1.36/0.0–72.9
Central memory CD8+ DP T cells (median/range)
0.09/0.0–1.17
0.04/0.0–1.17
Effector memory Tc17 cells (median/range)
0.14/0.0–1.64
0.025/0.00–0.09
Effector memory Tc1 cells (median/range)
10.27/0.27
0.45/0.0–83.54
Effector memory CD8+ DP T cells (median/range)
0.00/0.0–1.24
0.00/0.00–1.64
Wilcoxon test was used to compare Tc17 and Tc1 frequencies in peripheral blood and GALT. Significant values are highlighted in bold.